COR · Cencora, Inc.

Healthcare NYQ United States cencora.com ↗
Val Gro Qua Mom Sta Cap P/S0.18 P/E Fwd P/E16.24 PEG0.68 52W –  RSI Target$369.31 (+14.8%) Beta0.57 Div0.73%
Loading chart…
RSI ()
Pattern Overlays
Loading patterns…
Medical Distribution Conshohocken, United States 47,000 employees
Cencora, Inc. sources and distributes pharmaceutical products in the United States and internationally. The company's U.S. Healthcare Solutions segment distributes generic and injectable pharmaceuticals, over-the-counter healthcare products, home healthcare supplies and equipment, and related services to acute care hospitals and health systems, independent and chain retail pharmacies, mail order pharmacies, medical clinics, long-term care and alternate site pharmacies, and other customers; distributes plasma and other blood products, vaccines, and other specialty pharmaceutical products; provides pharmacy management, staffing, and other consulting services; supply management software to retail and institutional healthcare providers; packaging solutions to institutional and retail healthcare providers; clinical trial support, product post-approval, and commercialization support services; data analytics, outcomes research, and other services for biotechnology and pharmaceutical manufacturers; pharmaceuticals, vaccines, parasiticides, diagnostics, micro feed ingredients, and other products to the companion animal and production animal markets; sales force services to manufacturers; and offers other services to physicians who specialize in various disease states, such as oncology, as well as to other healthcare providers, including hospitals and dialysis clinics. Its International Healthcare Solutions segment provides international pharmaceutical wholesale and related service, and global commercialization services; distributes pharmaceuticals, other healthcare products, and related services to pharmacies, doctors, health centers, and hospitals; and offers specialty transportation and logistics services for the biopharmaceutical industry. The company was formerly known as AmerisourceBergen Corporation and changed its name to Cencora, Inc. in August 2023. Cencora, Inc. was founded in 1871 and is headquartered in Conshohocken, Pennsylvania.
Signal
Trend Strength
Price Levels
52-Week Range
52W Low 52W High
Position in Range
RSI (14)
0 · Oversold RSI 50 Overbought · 100
Signal Neutral
EMA Price Levels
Activity & Patterns
Volume Analysis
Momentum Dashboard
Detected Patterns
8Bullish
3Bearish
0Neutral

Key Signals 3

▲ Double Bottom Major reversal 2026-06-25 · $284.38
Two lows ~$264.78 — bullish reversal confirmed
Learn more →
▲ Double Bottom Major reversal 2026-08-06 · $322.33
Two lows ~$299.25 — bullish reversal confirmed
Learn more →
▲ Double Bottom Major reversal 2026-09-02 · $333.3
Two lows ~$301.33 — bullish reversal confirmed
Learn more →

Momentum Signals 8

▲ MACD Bullish Crossover 2026-05-20 · $264.24
▲ Bull Flag 2026-07-02 · $293.21
▲ MACD Bullish Crossover 2026-07-27 · $310.55
▲ Bull Flag 2026-07-28 · $313.29

View overlays on the price chart via Overview tab → Pattern Overlays.

Next Earnings Nov 04, 2026
Beat Rate 100%
Consensus BUY
Analyst Upside +14.8%
EPS — History & Forecast
Estimate Beat Miss Forecast
Loading…
Revenue — History & Forecast
Revenue Forecast
Loading…
EPS Beat Rate
100% 8/8 quarters
Wall Street Consensus
BUY
11
4
BuyHoldSell
Price Target Range
$369.31 +14.8% upside
Low $330 High $430
Consensus Current price
Wall Street Analyst Ratings
Sort by
Firm Rating Change Action Date
Profitability
Gross Margin 3.96%Last 12 Months
Operating Margin 1.41%Last 12 Months
Return on Equity 96.87%Last 12 Months
Revenue Growth 5.10%Year over Year
Free Cash Flow 2.04BLast 12 Months
Free Cash Flow Yield Last 12 Months
Balance Sheet
Debt / Equity 446.52Most Recent Quarter
Current Ratio 0.94Most Recent Quarter
Cash 2.82BMost Recent Quarter
Total Debt 14.46BMost Recent Quarter
Net Debt Most Recent Quarter
How COR Makes Its Money
Cash Flow Breakdown
Quarterly Metrics
QuarterRevenueRev YoYGross Profit Op. IncomeNet IncomeNet YoY Gross %Op %Net %
Full Key Statistics
Valuation
Market Cap61.36B
Enterprise Value73.20B
Trailing P/E23.86
Forward P/E16.24
PEG Ratio (5yr)0.68
Price/Sales (ttm)0.18
Price/Book (mrq)20.11
EV/Revenue0.22
EV/EBITDA13.20
Share Statistics
Avg Vol (3m)1.48M
Shares Outstanding190.83M
Float180.25M
% Held by Insiders4.30%
% Held by Institutions99.62%
Short Ratio3.16
Short % of Float2.70%
Profitability
Gross Margin3.96%
Operating Margin (ttm)1.41%
Profit Margin0.79%
Return on Assets (ttm)3.56%
Return on Equity (ttm)96.87%
Income Statement
Revenue (ttm)332.77B
Revenue Growth (yoy)5.10%
Gross Profit (ttm)13.18B
EBITDA5.55B
Net Income (ttm)2.62B
Diluted EPS (ttm)13.48
EPS Growth (yoy)11.90%
Balance Sheet
Total Cash (mrq)2.82B
Total Debt (mrq)14.46B
Debt / Equity (mrq)446.52
Current Ratio (mrq)0.94
Book Value / Share15.99
Operating CF (ttm)4.82B
Free Cash Flow (ttm)2.04B
Trading & Dividends
Beta (5Y)0.57
50-Day MA314.47
200-Day MA321.35
Fwd Dividend Yield0.75%
Payout Ratio17.45%
Income
Dividend Yield 0.73%Last 12 Months
Annual Rate 2.40Forward
Payout Ratio 17.45%Last 12 Months
Dividend History
Payout Ratio (Last 12 Months): 17.45%
Monthly Dividends
Ownership Breakdown
Institutional 99.62% Insider 4.30%
Short Interest 2.70% of float
Low
Institutional 13F Holdings

Famous investors who disclosed a position in COR in their latest SEC 13F filing.

Loading…
Insider Transactions
Date Insider Role Transaction Shares Price Value